An Israeli startup invented a cutting-edge approach of analyzing the real-world medical data to improve the quality of human life. Being its technical partner, Envion Software, made the idea possible by delivering software that aggregates, standardizes and validates the data on drugs, diseases, side effects, patients’ opinions, and their interrelations.
The startup provides its clients with healthcare insights based on statistical methodology and sentiment analysis. This way, they needed the data to be aggregated and presented in the appropriate structure. Envion used AWS to bring this Big Data project to life. With the help of the application developed by Envion, the data (both structured, and unstructured) from multiple sources:
is correlated and cross-referenced. This allows to capture the latest signals of a drug’s therapeutic or negative side effects.
Still exploring all the business potential, the provider of the healthcare insights has been rapidly growing its list of current and prospective partners. Interested to use the product’s analytics, pharmaceutical corporations can make reasonable marketing forecasts. Stock exchange players are now equipped to draw predictions on the financial markets’ indices of the the Pharmaceutical industry.